Study guide

6.3 Aerosol Deposition, Clearance, and Respiratory Tract Dosimetry

CIH Certified Industrial Hygienist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The CIH Exam and How to Use This Guide

1.1 CIH Exam Format, Scoring, and Test-Day Logistics 1.2 Eligibility, Application Windows, Fees, and Certification Maintenance 1.3 The BGC Blueprint, Subject Areas, and a Calculation-First Study Plan

2 Chapter 2: Basic Science & Calculations

2.1 Gas Laws and Vapor Calculations 2.2 Unit Conversions: ppm, mg/m³, and Standard Temperature/Pressure 2.3 Fluid Mechanics and Airflow Fundamentals

3 Chapter 3: Air Sampling & Instrumentation

3.1 Active and Passive Air Sampling Strategies 3.2 Particulate and Aerosol Sampling 3.3 Direct-Reading Instruments and Calibration

4 Chapter 4: Analytical Chemistry & Lab Methods

4.1 Gas Chromatography and Mass Spectrometry 4.2 High-Performance Liquid Chromatography and Ion Chromatography 4.3 Spectroscopy and Elemental Analysis 4.4 Gravimetric, Microscopy, and Wet Chemical Methods 4.5 Laboratory Quality Assurance, Chain of Custody, and Desorption Efficiency

5 Chapter 5: Biostatistics & Epidemiology

5.1 Lognormal Distributions and Exposure Data Statistics 5.2 Upper Confidence Limits (UCL95) and Compliance Decision Rules 5.3 Epidemiological Study Designs and Measures of Association 5.4 Sampling Strategy: Sample Size, Power, and Worker Selection

6 Chapter 6: Toxicology & Biological Monitoring

6.1 Dose-Response Relationships and Points of Departure 6.2 Toxicokinetics: Absorption, Distribution, Metabolism, and Elimination 6.3 Aerosol Deposition, Clearance, and Respiratory Tract Dosimetry 6.4 Hepatic, Renal, Neurologic, and Hematologic Target Organ Toxicity 6.5 Pulmonary Toxicology, Carcinogenicity, and Reproductive Hazards 6.6 OEL Frameworks, Classifications, and Excursion Limits 6.7 Chemical Mixtures and Extended Work-Shift OEL Adjustments 6.8 Biological Exposure Indices (BEIs) and Biomonitoring

7 Chapter 7: Biohazards & Indoor Environmental Quality

7.1 Mold, Fungi, and Microbial Contaminants 7.2 Infectious Agents, Bloodborne Pathogens, and Biosafety Levels 7.3 Indoor Environmental Quality (IEQ) Investigations 7.4 Sanitation, Potable Water, and Personal Hygiene Programs

8 Chapter 8: Community Exposure & Environmental Health

8.1 Clean Air Act Framework, NAAQS, and New Source Review 8.2 Hazardous Air Pollutants, CEMS, and EPA Reference Methods 8.3 Atmospheric Stability, Lapse Rates, and Plume Morphology 8.4 Gaussian Plume Modeling, Plume Rise, and Environmental Fate 8.5 HAZWOPER Scope, Mandates, and Training Tiers 8.6 Protection Levels, Site Zoning, Incident Command, and Decontamination 8.7 Water Pollution, Hazardous Waste, and Community Right-to-Know

9 Chapter 9: Health Risk Analysis & Hazard Communication

9.1 GHS Hazard Classification: Health and Physical Hazard Criteria 9.2 GHS Labels, Safety Data Sheets, and Trade Secret Rules 9.3 The AIHA Exposure Assessment Strategy and Similar Exposure Groups 9.4 Qualitative Exposure Profiling and the AIHA Risk Matrix 9.5 Quantitative Health Risk Characterization: HQ, HI, and ELCR 9.6 NIOSH Occupational Exposure Banding 9.7 Risk Communication and Reporting to Affected Parties

10 Chapter 10: Industrial Ventilation Principles & LEV Design

10.1 Elimination, Substitution, Isolation, Containment, and Process Change 10.2 LEV Hood Taxonomy and Capture Velocity Selection 10.3 Hood Airflow Equations, Entry Losses, and Hood Static Pressure 10.4 Particulate Transport Aerodynamics and Duct Sizing 10.5 Duct Friction, Fitting Losses, and System Balancing 10.6 Fan Categories and Pressure Dynamics Across the Fan 10.7 System Curves, the Fan Laws, and Density Corrections

11 Chapter 11: General Ventilation, Air Cleaning & Diagnostics

11.1 Dilution Ventilation Principles and Steady-State Modeling 11.2 Transient Purging and Air Distribution Geometry 11.3 Particulate Air Cleaning: Cyclones, Baghouses, Scrubbers, and ESPs 11.4 Gaseous Emission Control and Air Cleaner Selection 11.5 Ventilation System Troubleshooting and Testing

12 Chapter 12: Noise Measurement & Hearing Conservation

12.1 Acoustic Physics and Decibel Mathematics 12.2 Sound Propagation, Octave Bands, and Frequency Weighting 12.3 Noise Dose Metrics and OSHA versus ACGIH Criteria 12.4 Exchange Rates, Extended Shifts, and Dosimetry Field Protocols 12.5 Engineering Noise Controls and Hearing Protector Attenuation 12.6 Hearing Conservation Programs and Standard Threshold Shifts 12.7 Hand-Arm and Whole-Body Vibration

13 Chapter 13: Thermal Stress Assessment & Control

13.1 Wet Bulb Globe Temperature (WBGT) and Heat Stress Indices 13.2 Heat-Related Disorders, Acclimatization, and Work/Rest Regimens 13.3 Cold Stress Evaluation and Wind Chill

14 Chapter 14: Ionizing Radiation Protection

14.1 Ionizing Radiation Physics and Radioactive Decay Kinetics 14.2 Radiation Units, Radiobiology, and Health Effects 14.3 ALARA, Stay-Time, and the Inverse Square Law 14.4 Shielding Physics, Material Selection, and Gamma Constants 14.5 Radiation Detection Instruments and Spectrometry 14.6 Personnel Dosimetry, Dose Limits, and Contamination Surveys

15 Chapter 15: Non-Ionizing Radiation & Laser Safety

15.1 The Non-Ionizing Spectrum and Static/ELF Field Exposures 15.2 Radiofrequency and Microwave Exposure: SAR, Standards, and Surveys 15.3 Ultraviolet, Visible, and Infrared Radiation Hazards 15.4 Laser Safety Classifications and Optical Density Calculations 15.5 Illumination, Lighting Design, and Visual Performance

16 Chapter 16: Non-Engineering Controls & Personal Protective Equipment

16.1 Respiratory Protection Programs and Assigned Protection Factors 16.2 Maximum Use Concentration, Oxygen Deficiency, and Breathing Air 16.3 Particulate Filters, Sorbent Cartridges, and Change Schedules 16.4 Respirator Fit Testing Protocols 16.5 Chemical Protective Clothing and Dermal Exposure Control

17 Chapter 17: Ergonomics & Workstation Design

17.1 Soft-Tissue Biomechanics and WMSD Pathophysiology 17.2 Ergonomic Risk Factors and Their Interaction Effects 17.3 The Revised NIOSH Lifting Equation 17.4 RULA, REBA, the Strain Index, and the ACGIH HAL TLV 17.5 Anthropometry and Workstation Geometry 17.6 VDT Workstations, Hand Tool Design, and Administrative Ergonomics

18 Chapter 18: Work Environments & Industrial Processes

18.1 Welding Fume Emissions, Metal Fume Fever, and Cr(VI)/Manganese Toxicology 18.2 Foundry Operations and Hot Work Fire Prevention 18.3 Vapor Degreasing, Pickling, Electroplating, and Cyanide Baths 18.4 Spray Coatings, Isocyanates, and Semiconductor Manufacturing 18.5 Confined Spaces and High-Hazard Industrial Operations 18.6 Asbestos, Lead, and Silica: Regulated Substance Programs 18.7 Abrasive Blasting and Surface Preparation

19 Chapter 19: IH Program Management & Professional Ethics

19.1 The BGC Code of Ethics: Canons and Enforcement 19.2 Professional Liability, Standard of Care, and Expert Testimony 19.3 Occupational Health & Safety Management Systems (ISO 45001, ANSI Z10) 19.4 Exposure Records Access and Medical Surveillance 19.5 OSHA Injury and Illness Recordkeeping and Enforcement

6.3 Aerosol Deposition, Clearance, and Respiratory Tract Dosimetry

Key Takeaways Explain This Topic AI

Three mechanisms dominate deposition: inertial impaction above about 5 µm, gravitational sedimentation between roughly 1 and 5 µm, and Brownian diffusion below about 0.5 µm.

Total deposition efficiency reaches a minimum near 0.3 to 0.5 µm, where particles are too small to impact or settle and too large to diffuse efficiently.

The ACGIH and ISO/CEN size-selective conventions define inhalable (50% cut at 100 µm), thoracic (50% cut at 10 µm), and respirable (50% cut at 4 µm) fractions.

Mucociliary clearance removes deposited material from the conducting airways within about 24 hours, while alveolar macrophage clearance operates over months to years.

Fibres deposit according to aerodynamic diameter, which is roughly three times the physical fibre diameter, so long thin fibres reach the alveolar region despite their length.

Last updated: August 2026

Aerosol Deposition, Clearance, and Respiratory Tract Dosimetry

The BGC subject area definition for Toxicology names aerosol deposition and clearance in the respiratory tract explicitly. It is the hinge between air sampling and toxicology: a filter measures what is in the air, but disease is caused by what is deposited, where it deposits, and how long it stays. Two aerosols with identical mass concentrations can produce completely different doses to the alveolar region.

1. Deposition Mechanisms

Five mechanisms remove particles from inhaled air. Three dominate.

  • Mechanism Governing property Dominant size range Principal site
  • Inertial impaction Momentum (mass × velocity) above ~5 µm Nasopharynx, airway bifurcations
  • Gravitational sedimentation Settling velocity (Stokes) ~1 to 5 µm Bronchi, bronchioles
  • Brownian diffusion Thermal motion below ~0.5 µm Alveoli
  • Interception Particle length/shape Fibres Airway walls
  • Electrostatic attraction Charge Freshly generated aerosols Variable

Impaction occurs when a particle's momentum carries it straight on while the airstream turns — at the back of the throat, at the carina, and at every subsequent bifurcation. It is why high inspiratory flow rates (heavy work, mouth breathing) shift deposition upward and increase total deposition of coarse particles.

Sedimentation requires residence time. It dominates in the small airways where air velocity is low, and it is enhanced by breath-holding.

Diffusion dominates for ultrafine particles, whose random thermal motion carries them to a wall during the residence time of a breath. Diffusional deposition increases as particle size falls, which is why nanoparticles deposit efficiently in the alveolar region.

The deposition minimum

Because impaction and sedimentation both fall as size decreases while diffusion rises, total deposition efficiency passes through a minimum near 0.3 to 0.5 µm : Deposition

  • efficiency |* *
  • | * *
  • | * *
  • | * *
  • | * *
  • | * *
  • | * *
  • | * *
  • +----------------------------------------- Aerodynamic diameter
  • 0.01 0.1 0.3-0.5 1 5 10 (um)
  • MINIMUM

The same physics explains why 0.3 µm is the standard filter test particle size : it is the most penetrating particle size, so a filter certified at 0.3 µm performs at least as well everywhere else. An N95 is 95% efficient at its worst case , not on average.

2. Regional Anatomy and the Size-Selective Conventions

Region Anatomy Deposits Clearance

Head airways (extrathoracic) Nose, mouth, pharynx, larynx Coarse particles by impaction Rapid: sneezing, blowing, swallowing

Tracheobronchial Trachea to terminal bronchioles Mid-size by impaction and sedimentation Mucociliary escalator, hours to ~24 h

Alveolar (gas exchange) Respiratory bronchioles, alveoli Fine and ultrafine by sedimentation and diffusion Macrophages, months to years

The ACGIH and ISO/CEN size-selective sampling conventions are direct expressions of this physiology:

Fraction 50% cut point Health rationale

Inhalable 100 µm Everything that enters the nose or mouth; relevant for agents acting anywhere in the respiratory tract or after swallowing

Thoracic 10 µm Penetrates past the larynx; relevant for agents acting on the airways, such as asthmagens

Respirable 4 µm Reaches the gas-exchange region; relevant for silica, coal dust, asbestos, and other alveolar toxicants

This is why a respirable silica sample uses a cyclone with a 4 µm cut and a lead sample does not: the toxicological target differs.

3. Clearance

Mucociliary clearance. The conducting airways are lined with ciliated epithelium covered by a mucus blanket. Coordinated ciliary beating moves the blanket upward at roughly 1 to 10 mm per minute, carrying deposited particles to the pharynx where they are swallowed. Most material deposited in this region is cleared within about 24 hours . Cigarette smoke, ozone, sulphur dioxide, and cold dry air all impair ciliary function and prolong retention.

Alveolar macrophage clearance. The alveolar region has no cilia. Particles are phagocytosed by alveolar macrophages, which migrate to the mucociliary escalator or into the lymphatic system. This is slow — a half-time of months to years — and it is the reason alveolar-deposited dusts produce chronic rather than acute disease.

Dissolution and translocation. Soluble particles dissolve and are absorbed directly into blood or lymph. Insoluble ultrafine particles can translocate across the alveolar epithelium into the interstitium and systemic circulation.

Particle overload

At high dust burdens the macrophage clearance mechanism saturates: macrophages become engorged, mobility falls, and clearance slows dramatically. Retained dose then rises faster than exposure, producing a non-linear dose-response. This overload phenomenon underlies the pulmonary responses seen in high-dose rodent studies of poorly soluble low-toxicity dusts, and it complicates extrapolation from those studies to workplace exposures.

4. Fibres Behave Differently

For a fibre, aerodynamic diameter is governed almost entirely by the fibre's diameter, not its length — approximately three times the physical diameter for a long fibre. A 20 µm long, 0.5 µm diameter asbestos fibre has an aerodynamic diameter around 1.5 µm and therefore reaches the alveolar region readily, while a 20 µm compact particle would impact in the upper airway.

This is the basis of the fibre pathogenicity paradigm : long (greater than about 20 µm), thin, and biopersistent fibres are the dangerous ones. They deposit deep because they are thin, they cannot be fully phagocytosed because they are long — producing frustrated phagocytosis and sustained inflammation — and they are not cleared because they do not dissolve. Interception, not impaction, is the mechanism that brings fibres into contact with airway walls.

5. Why This Governs Sampling and Control Decisions

Selecting a cyclone versus a total dust cassette is a toxicological decision about where the agent acts, not a convention.

A mass concentration says nothing about particle size distribution ; two welding operations at the same mg/m³ can deliver very different alveolar doses.

Ultrafine and engineered nanoparticle exposures deposit efficiently in the alveolar region and may translocate systemically, so mass concentration alone is a poor exposure metric for them — surface area or number concentration is more relevant.

A worker doing heavy work breathes faster and deeper and shifts from nasal to oral breathing, which increases both total deposition and the fraction reaching the deep lung at the same airborne concentration.